CLINICAL_TRIALS
trial_result
· 2015-05-27
Clinical Trial Update: Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 trial update of axitinib for advanced hepatocellular carcinoma has completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-05-27